| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |